Skip to content
All news
General

Pfizer's Former Headquarters Crumbles Alongside Its Stock

Construction at Pfizer's former Manhattan headquarters halted Tuesday due to crumbling floors and structural issues. The building, sold eight years ago for apartment conversion, mirrors the stock's poor performance. Pfizer shares began Tuesday with the highest dividend yield in the S&P 500 at over 7%.

July 7, 2026
2 min read
Source: Barrons.com
Share:

Key Numbers

stock price
$24.10
daily change
+1.6%
dividend yield
>7%
worst performer 2026
yes
worst performer 10yr
yes

Construction at Pfizer's (PFE) former headquarters in Manhattan was halted Tuesday due to crumbling floors and other structural issues, according to reports. The building, which the company sold about eight years ago for conversion to apartments, has become a metaphor for Pfizer stock, which began Tuesday with the highest yield in the S&P 500 at over 7%.

Details

The building in midtown Manhattan suffers from structural deterioration that led to a halt in construction. Issues include cracked floors and weak structures, raising safety concerns.

Context

Pfizer stock (PFE) rose 1.6% to $24.10 on Tuesday, but remains the worst performer among its large-cap U.S. pharma peers during 2026 and over the past 10 years. The high dividend yield reflects the stock's low price rather than strong dividend growth.

What This Means for Investors

The structural issues at the former headquarters do not directly impact Pfizer's current operations, but they serve as a reminder of the stock's poor performance and weak investor confidence. The high yield may attract income-seeking investors, but the historically weak performance warrants caution.

Frequently Asked Questions

Construction halted due to structural issues including crumbling floors and weak structures.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.